Product Pathways
BCP0005 Gemcitabine Hydrochloride
A new pyrimidine antimetabolite which has shown good clinical activ.A nucleoside analog of deoxycytidine used in chemotherapy to treat various types of cancer.
BCP0039 Capecitabine(Xeloda)
Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
BCP0310 Dyphylline(Dilor)
Dyphylline(Dilor, Lufyllin, diprophylline) is a xanthine derivative with bronchodilator and vasodilator effects.
BCP0316 Tadalafil(Cialis)
Tadalafil(Cialis) is a PDE inhibitor.
BCP0355 Fludarabine(Fludara)
Fludarabine (Fludara, F-ara-A, NSC 118218) is a STAT1 activation inhibitor and a DNA synthesis inhibitor.
BCP0488 Parogrelil
Selective and potent PDE III (PDE3) inhibitor.
BCP000566 PDE-9
PDE-9 inhibitor is usefol for neurodegenerative diseases.
BCP000662 Ibudilast
Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency Virus-1 Tat-Mediated activation of microglial cells.
BCP000718 Cilomilast
Cilomilast(SB-207499) is among the first of a new generation of PDE4 inhibitors (Ki ?100 nM).
BCP000927 GSK256066
GSK256066 is a selective phosphodiesterase 4 inhibitor that can be given by inhalation, minimising the potential for side effects. We evaluated the effects of GSK256066 on airway responses to allergen challenge in mild asthmatics.
第一页 1 2 3 4 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.